Designing de novo miniprotein medicines
AI Proteins (aiproteins.bio) earns a Brand Analyzer score of 70 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, AI Proteins ranks in the 62nd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 93/100, Digital Presence 82/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 70/100, AI Discoverability 76/100, Brand Authority 17/100.
AI Proteins is a biotechnology company that designs de novo miniproteins using artificial intelligence, robotics, and synthetic biology. Rather than modifying naturally occurring proteins, the company engineers miniproteins entirely from first principles, unconstrained by evolution. Its goal is to create a new class of biologics characterized by precision, programmability, and safety. AI Proteins targets pharmaceutical partners seeking innovative biologic drug candidates and positions its miniproteins as a next-generation therapeutic modality validated through laboratory research.
| Brand Name | AI Proteins |
|---|---|
| Domain | aiproteins.bio |
| Industry | Healthcare, Technology |
| Main Competitors | Arzeda, Absci, Generate Biomedicines, Evozyne, BigHat Biosciences, Relay Therapeutics |
Moz Domain Authority 22/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "AI Proteins pioneers programmable miniproteins-engineered from scratch with AI, robotics, and synthetic biology to create safer, more precise biologics for patients." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, og:image, og:type, Twitter cards. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
AI Proteins scores 19/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
AI Proteins has a weak AI-visibility profile at 19/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (43/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 22/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
AI Proteins's main competitors include Arzeda, Absci, Generate Biomedicines, Evozyne, BigHat Biosciences. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: AI Proteins official site
Popular alternatives to AI Proteins include Arzeda, Absci, Generate Biomedicines, Evozyne, BigHat Biosciences. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: AI Proteins official site
AI Proteins offers de novo miniproteins as its core product-engineered from scratch using AI, robotics, and synthetic biology. These miniproteins are described as potent, programmable, and safe biologics representing a new class of medicines. The company's value proposition centers on designing these therapeutic molecules entirely from first principles, unconstrained by natural protein evolution, and validating them in the laboratory. Its services are directed at pharmaceutical partners for drug development purposes.
Sources: AI Proteins official site
AI Proteins has low AI-search visibility, scoring 19/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 26, recommendation 43). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: AI Proteins official site
AI Proteins is a biotechnology company that pioneers programmable miniproteins engineered entirely from scratch. It operates at the intersection of artificial intelligence, robotics, and synthetic biology, using these tools to design miniproteins from first principles rather than adapting naturally evolved proteins. The company positions its work as creating a next-generation modality of therapeutics-de novo miniproteins intended to be safer, more precise, and more programmable than conventional biologics. Its focus is on developing these as a new class of medicines for use by pharmaceutical partners.
Sources: AI Proteins official site
AI Proteins designs miniproteins entirely from first principles using AI, robotics, and synthetic biology. Unlike approaches that modify existing natural proteins, the company builds its miniproteins de novo-unconstrained by evolutionary history-enabling greater speed, scale, and precision in design. These engineered miniproteins are intended to function as potent, programmable, and safe biologics. The company validates its designs in the laboratory and works with pharmaceutical partners to advance these miniproteins toward drug development applications.
Sources: AI Proteins official site
AI Proteins and Arzeda are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: AI Proteins official site
AI Proteins scores 43/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: AI Proteins official site
AI Proteins is known for pioneering de novo miniproteins-engineered proteins built entirely from scratch using artificial intelligence rather than derived from naturally occurring proteins. The company is recognized for its first-principles design approach, which it argues is unconstrained by evolution, allowing for greater programmability and precision. Its miniproteins are positioned as a new class of biologics that are safer and more precise than traditional protein-based medicines, validated through laboratory research.
Sources: AI Proteins official site
According to the available information, AI Proteins' primary audience is pharmaceutical partners and companies seeking innovative, precise biologics for drug development. The company positions its de novo miniproteins as a new therapeutic modality suited for organizations looking to expand or improve their biologic drug pipelines. The end beneficiaries of the resulting medicines would be patients, as stated in the company's mission, though patients are not direct customers of AI Proteins itself.
Sources: AI Proteins official site
AI Proteins can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: AI Proteins official site
Ranked closest to AI Proteins: AiCure (70/100), Aiberry (70/100), allsynx (70/100), Amperos (70/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).